Chimin(603222)

Search documents
12天6板济民健康:明显异常,后续可能随时有快速下跌风险
Bei Ke Cai Jing· 2025-09-12 01:14
Group 1 - The core point of the article highlights the significant stock price movements of Jimin Health, with a closing price increase of 33.78% from September 8 to September 11, 2025 [1] - The stock experienced a trading limit increase on September 11, with a turnover rate of 16.96%, indicating high trading activity [1] - Over the past 30 trading days, the stock's price deviation from the Shanghai A-share index reached 94.72%, suggesting substantial volatility in its trading performance [1] Group 2 - The company has shown a pattern of large price fluctuations, with multiple trading days experiencing rapid increases and decreases [1] - There is a warning regarding the potential for a quick decline in stock price due to the observed trading anomalies [1]
晚间公告丨9月11日这些公告有看头
第一财经· 2025-09-11 13:55
Key Points - The article summarizes important announcements from various listed companies in the Shanghai and Shenzhen stock markets on September 11, 2025 [3] Group 1: Major Events - Taihe Intelligent announced that Sunshine New Energy will acquire 5.79% of its shares from shareholder Xu Dahong at a price of 22.35 yuan per share, totaling 237 million yuan [4] - Chengdi Xiangjiang received a warning letter from the Shanghai Securities Regulatory Commission due to inaccuracies in financial data disclosure in its annual and quarterly reports [5][6] - Sike Rui terminated its capital increase agreement with Changying Hengrong due to external factors, which will not impact its financial status [7] - Jinko Technology plans to invest 30 million USD in an overseas private equity fund to explore applications of new technologies [8] - Western Gold's subsidiary will undergo equipment maintenance until the end of the year, affecting its production capacity [9] Group 2: Share Transfers - Daye Intelligent's actual controller plans to transfer 8% of the company's shares to a private equity fund at a price of 6.75 yuan per share, totaling 171 million yuan [10] - Jimin Health's stock has seen significant fluctuations, with a recent increase of 33.78% over a few days, raising concerns about potential rapid declines [14] Group 3: Acquisitions and Investments - Yangjie Technology intends to acquire 100% of Better Electronics for 2.218 billion yuan, which will become a wholly-owned subsidiary [15] - *ST Jinke's stock will resume trading on September 12, 2025, following a capital increase plan [16] Group 4: Contracts and Projects - Haixia Environmental plans to sign a contract for a photovoltaic microgrid energy management project with its controlling shareholder, with expected transactions not exceeding 21 million yuan [18] - Jilin Expressway's subsidiary won a construction project worth 9.592 billion yuan [19] - *ST Songfa's subsidiary signed contracts for the construction of four container ships, with a total value between 300 million and 500 million USD [20] Group 5: Shareholder Actions - Baicheng Pharmaceutical's controlling shareholder raised the share buyback price to no more than 80 yuan per share [21] - Mountain Outside Mountain's shareholders plan to reduce their holdings by up to 4.08% [22] - Jinpu Garden's shareholders plan to reduce their holdings by up to 4.58% [24] - Suqian Liansheng's shareholder plans to reduce their holdings by up to 3% [25] Group 6: Financing and Debt - CITIC Securities received approval to publicly issue bonds totaling up to 60 billion yuan [34]
首开股份:控股子公司间接持有宇树科技约0.3%股权;芯原股份明日复牌丨公告精选
2 1 Shi Ji Jing Ji Bao Dao· 2025-09-11 13:49
Group 1 - China Shipbuilding has completed the share swap absorption merger with China Shipbuilding Industry Corporation, with 3.053 billion new shares listed on September 16, 2025 [1] - Transsion Holdings' shareholder plans to transfer 2% of the company's shares, amounting to approximately 22.807 million shares [1] Group 2 - Chipone Technology reported a record high in new orders from July 1 to September 11, 2025, totaling 1.205 billion yuan, with AI computing orders accounting for about 64% [2] - Chipone Technology's total order amount reached 3.025 billion yuan by the end of the second quarter of 2025, indicating a significant increase [2] Group 3 - Chipone Technology plans to acquire 97.0070% equity of Chipai Technology through a combination of share issuance and cash payment, with the stock resuming trading on September 12 [3] Group 4 - Xinjun Network received a notice of share reduction from its major shareholder, Shanghai Senxiao Investment Center, which reduced its holdings by 1.6271 million shares, bringing its ownership down to 5.29% [4] Group 5 - Yangjie Technology intends to acquire 100% equity of Better Electronics for 2.218 billion yuan, with a profit commitment of no less than 555 million yuan from 2025 to 2027 [5] Group 6 - Shoukai Co. announced that its subsidiary, Yingxin Company, indirectly holds approximately 0.3% equity in Yushu Technology, indicating a low ownership stake [6] Group 7 - Xiamen Airport reported a total passenger throughput of 2.707 million in August, representing a year-on-year increase of 5.18% [9] - *ST Tianshan experienced a significant decline in livestock sales revenue, down 95.80% year-on-year in August [9] Group 8 - Taihe Intelligent's shareholder plans to transfer 5.79% of the company's shares to Sunshine New Energy [9] - Jilin Expressway's subsidiary won a construction project worth 9.592 billion yuan [9] - Tianyong Intelligent secured a project with SAIC Group for engine assembly line renovation [9]
济民健康(603222.SH):目前股价走势与经营业绩趋势明显偏离
智通财经网· 2025-09-11 12:04
Core Viewpoint - Jimin Health (603222.SH) has issued a risk warning due to significant stock price fluctuations and a notable divergence from its operational performance, indicating potential risks for investors [1] Stock Performance - The company's stock closed at a daily limit increase, with a turnover rate of 16.96% - From September 8 to 11, 2025, the cumulative increase in closing price reached 33.78% - Over the past 30 trading days, the stock's price deviation from the Shanghai A-share index has accumulated to 94.72% [1] Financial Performance - For the fiscal year 2024, the net profit attributable to the parent company was -59.71 million yuan - In the first half of 2025, the net profit attributable to the parent company was -52.70 million yuan - The company is currently in a loss position, and its stock price trend is significantly deviating from its operational performance [1]
济民健康:目前股价走势与经营业绩趋势明显偏离
Ge Long Hui A P P· 2025-09-11 11:37
Core Viewpoint - Jimin Health's stock has experienced significant volatility, with a recent closing price increase leading to a trading halt, despite the company reporting substantial losses in its financial performance [1] Summary by Relevant Sections Stock Performance - Jimin Health's stock closed at a limit up today, with a turnover rate of 16.96% - From September 8 to 11, 2025, the cumulative closing price increase reached 33.78% - The stock's deviation from the Shanghai A-share index over the past 30 trading days amounted to 94.72% [1] Financial Performance - For the fiscal year 2024, the net profit attributable to the parent company was -59.71 million yuan - In the first half of 2025, the net profit attributable to the parent company was -52.70 million yuan - The company is currently in a loss-making state, with no changes in its main business operations [1] Market Behavior - The stock has shown significant abnormal trading behavior, with multiple days of sharp price increases and decreases - There is a potential risk of a rapid decline in stock price in the future, given the disconnect between stock price trends and operational performance [1]
济民健康:股票交易存在明显异常,后续可能随时有快速下跌风险
Di Yi Cai Jing· 2025-09-11 11:08
Core Viewpoint - The company, Jimin Health, has issued a stock trading risk warning as its stock price has experienced significant volatility, with a recent closing price increase leading to concerns about potential rapid declines in the future [1] Summary by Relevant Sections Stock Performance - The company's stock closed at a daily limit increase, with a turnover rate of 16.96% [1] - From September 8 to September 11, 2025, the cumulative closing price increase reached 33.78% [1] - Over the past 30 trading days, the stock's increase has deviated from the Shanghai A-share index by a cumulative 94.72% [1] Trading Anomalies - The stock has shown significant fluctuations, with multiple trading days experiencing consecutive large increases and decreases [1] - There is a clear indication of abnormal trading activity, suggesting potential risks for investors [1] Financial Performance - The company is currently in a state of loss, with no changes in its main business operations [1] - The stock price trend is noticeably diverging from the company's operational performance [1]
济民健康(603222) - 济民健康管理股份有限公司股票交易风险提示公告
2025-09-11 11:04
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重大风险提示: ●公司股票今日收盘再次涨停,换手率达到 16.96%,自 2025 年 9 月 8 日至 11 日,收盘价格累计涨幅达 33.78%,近 30 个交易日涨幅与上证 A 指偏离值累计 达 94.72%,剔除大盘和板块整体因素后的实际涨跌幅波动较大,多个交易日连续 大涨大跌,股票交易存在明显异常,后续可能随时有快速下跌风险。 ●2024 年度归属于母公司所有者的净利润为-5,971.17 万元;2025 年半年度, 公司实现归属于母公司所有者的净利润为-5,269.59 万元。公司业绩处于亏损状态, 主营业务未发生变化,目前股价走势与经营业绩趋势明显偏离。 ●公司控股股东于 2025 年 9 月 5 日披露了减持股份计划,计划以集中竞价交 易方式和大宗交易方式减持公司合计不超过 15,752,718 股股份,即不超过公司总 股本的 3%。 敬请广大投资者注意二级市场交易风险,理性决策,审慎投资。 证券代码:603222 证券简称:济民健康 公告编号:2025-0 ...
济民健康:股票交易存在明显异常 后续可能随时有快速下跌风险
Mei Ri Jing Ji Xin Wen· 2025-09-11 10:57
每经AI快讯,9月11日,济民健康(603222)(603222.SH)公告称,公司股票今日收盘再次涨停,换手率 达到16.96%,自2025年9月8日至11日,收盘价格累计涨幅达33.78%,近30个交易日涨幅与上证A指偏离 值累计达94.72%,剔除大盘和板块整体因素后的实际涨跌幅波动较大,多个交易日连续大涨大跌,股 票交易存在明显异常,后续可能随时有快速下跌风险。 ...
12天6板济民健康:股票交易存在明显异常,后续可能随时有快速下跌风险
Xin Lang Cai Jing· 2025-09-11 10:54
济民健康股票交易风险提示公告,公司股票今日收盘再次涨停,换手率达到16.96%,自2025年9月8日 至11日,收盘价格累计涨幅达33.78%,近30个交易日涨幅与上证A指偏离值累计达94.72%,剔除大盘和 板块整体因素后的实际涨跌幅波动较大,多个交易日连续大涨大跌,股票交易存在明显异常,后续可能 随时有快速下跌风险。 ...
创新药概念反弹回升
Di Yi Cai Jing· 2025-09-11 10:44
Group 1 - Jimin Health has experienced a significant increase, with 6 consecutive trading limits reached in 12 days [1] - Shutai Shen has risen over 7%, indicating strong market interest [1] - Hot景生物 has seen an increase of over 5%, reflecting positive investor sentiment [1] Group 2 - Other companies such as Meidi Xi, Guangsheng Tang, and Borui Pharmaceutical have also shown upward trends in their stock prices [1]